These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35989815)

  • 21. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Li-Fraumeni Syndrome with Unusual Synchronous Malignancies: A Case Report.
    Al Mansor E; Adamiak A; Asmis T
    Case Rep Oncol; 2024; 17(1):49-55. PubMed ID: 38188481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnosis and clinical outcome of a lung cancer patient with
    Yang D; Han X; Li D; Cui S; Liu S; Wu X; Dai Z
    Am J Transl Res; 2020; 12(10):6689-6693. PubMed ID: 33194065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.
    Funato M; Tsunematsu Y; Yamazaki F; Tamura C; Kumamoto T; Takagi M; Kato S; Sugimura H; Tamura K
    Cancer Sci; 2021 May; 112(7):2821-34. PubMed ID: 33932062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
    Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.
    Kast K; Krause M; Schuler M; Friedrich K; Thamm B; Bier A; Distler W; Krüger S
    BMC Cancer; 2012 Jun; 12():217. PubMed ID: 22672556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations.
    Klein JD; Kupferman ME
    Head Neck; 2017 Feb; 39(2):E20-E22. PubMed ID: 27726232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Variant in the
    Papadimitriou DT; Stratakis CA; Kattamis A; Glentis S; Dimitrakakis C; Spyridis GP; Christopoulos P; Mastorakos G; Vlahos NF; Iacovidou N
    Children (Basel); 2023 Jun; 10(7):. PubMed ID: 37508646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Li-Fraumeni Syndrome: Imaging Features and Guidelines.
    Gosangi B; Dixe de Oliveira Santo I; Keraliya A; Wang Y; Irugu D; Thomas R; Khandelwal A; Rubinowitz AN; Bader AS
    Radiographics; 2024 Aug; 44(8):e230202. PubMed ID: 39024172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of a
    Cotter JA; Szymanski L; Karimov C; Boghossian L; Margol A; Dhall G; Tamrazi B; Varaprasathan GI; Parham DM; Judkins AR; Biegel JA
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29581140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.
    Ponti F; Corsini S; Gnoli M; Pedrini E; Mordenti M; Sangiorgi L
    Fam Cancer; 2016 Oct; 15(4):635-43. PubMed ID: 26956143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family.
    Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M
    J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare
    AlHarbi M; Mubarak N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; AlJabarat W; Alqubaishi F; Al-Subaie L; AlTassan N; Neben CL; Zhou AY; Abedalthagafi M
    NPJ Genom Med; 2018; 3():35. PubMed ID: 30588330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.
    Hettmer S; Archer NM; Somers GR; Novokmet A; Wagers AJ; Diller L; Rodriguez-Galindo C; Teot LA; Malkin D
    Cancer; 2014 Apr; 120(7):1068-75. PubMed ID: 24382691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel germline mutation of TP53 with breast cancer diagnosed as Li-Fraumeni syndrome.
    Kai M; Kubo M; Shikada S; Hayashi S; Morisaki T; Yamada M; Takao Y; Shimazaki A; Harada Y; Kaneshiro K; Mizuuchi Y; Shindo K; Nakamura M
    Surg Case Rep; 2022 Oct; 8(1):197. PubMed ID: 36219266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome.
    Cruz O; Caloretti V; Salvador H; Celis V; Santa-Maria V; Morales La Madrid A; Suñol M; Puerta P; Muchart J; Krauel L; Lavarino C
    Hered Cancer Clin Pract; 2021 Jan; 19(1):1. PubMed ID: 33407742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
    Petry V; Bonadio RC; Cagnacci AQC; Senna LAL; Campos RDNG; Cotti GC; Hoff PM; Fragoso MCBV; Estevez-Diz MDP
    Fam Cancer; 2020 Jan; 19(1):47-53. PubMed ID: 31748977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report.
    Bondy S; Tajzler C; Hotte SJ; Kapoor A; Zbuk K; Lalani AA
    Curr Oncol; 2020 Dec; 28(1):226-232. PubMed ID: 33704190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.
    Valdez JM; Nichols KE; Kesserwan C
    Br J Haematol; 2017 Feb; 176(4):539-552. PubMed ID: 27984644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.